Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients

NCT: NCT06009159 · RECRUITING

NCT IDNCT06009159
StatusRECRUITING
Start Date2024-07-01
Completion2029-10-31
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

Fibromyalgia (FM) is a syndrome with clinical symptoms involving multiple systems. The efficacy of current treatments is inadequate, and more alternative modalities are needed for the management of FM patients. The parasympathetic vagus nerve innervates and integrates sensory, motor, and autonomic systems and has been suggested to play a role in pain modulation. The role of vagus nerve stimulation (VNS) as a treatment option for FM patients is yet to be investigated. The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM patients.

Frequently Asked Questions

What is Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients?

Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients is a clinical trial registered under NCT06009159. Current status: RECRUITING.

What is the status of NCT06009159?

The current status of NCT06009159 (Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients) is: RECRUITING.

When did Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients start?

Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients started on 2024-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.